Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-21-001760
Filing Date
2021-02-02
Accepted
2021-02-02 16:29:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 mbrx20210201b_424b5.htm 424B5 508895
2 m1.jpg GRAPHIC 9164
  Complete submission text file 0001437749-21-001760.txt   522604
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-235686 | Film No.: 21581822
SIC: 2834 Pharmaceutical Preparations